Quantitative Health Sciences

Medicine & Life Sciences

1. Colorectal Neoplasms 100%
2. Neoplasms 99%
3. Cognitive Dysfunction 93%
4. Breast Neoplasms 72%
5. Patient Reported Outcome Measures 70%
6. Mutation 50%
7. Hereditary Nonpolyposis Colorectal Neoplasms 47%
8. Radiotherapy 43%
9. Dementia 42%
10. Survival 42%
11. Confidence Intervals 40%
12. Quality of Life 37%
13. Smoking Cessation 37%
14. Trastuzumab 37%
15. Therapeutics 36%
16. Population 36%
17. Registries 34%
18. Alzheimer Disease 32%
19. Genes 32%
20. Colonic Neoplasms 31%
21. Tobacco 28%
22. Terminology 28%
23. Clinical Trials 27%
24. T-Lymphocytes 26%
25. Ovarian Neoplasms 25%
26. Radiosurgery 25%
27. Amyloid 24%
28. Depression 24%
29. Apolipoprotein E4 24%
30. Research Personnel 22%
31. Primary Myelofibrosis 22%
32. Proton Therapy 21%
33. Drug Therapy 21%
34. Hemorrhage 21%
35. Polycythemia Vera 20%
36. Biomarkers 20%
37. Odds Ratio 20%
38. Cognition 20%
39. Genome-Wide Association Study 19%
40. Non-Small Cell Lung Carcinoma 19%
41. Tobacco Use Cessation 18%
42. Elderly 18%
43. Breast 18%
44. Smokers 18%
45. National Cancer Institute (U.S.) 17%
46. Smoking 17%
47. Recurrence 17%
48. Tobacco Products 17%
49. Lapatinib 16%
50. Radiation 16%
51. Cohort Studies 16%
52. Guidelines 15%
53. Tobacco Use Cessation Devices 15%
54. Cognitive Aging 15%
55. Alleles 15%
56. human ERBB2 protein 15%
57. Melanoma 15%
58. Anticoagulants 15%
59. Prostatic Neoplasms 15%
60. Anxiety 14%
61. Electronic Nicotine Delivery Systems 14%
62. Placebos 14%
63. Phenotype 14%
64. Health 14%
65. Incidence 14%
66. Germ-Line Mutation 14%
67. Glioblastoma 14%
68. Immunity 14%
69. Essential Thrombocythemia 13%
70. Tobacco Use 13%
71. Hispanic Americans 13%
72. Barrett Esophagus 13%
73. Consensus 13%
74. Genome 12%
75. Prospective Studies 12%
76. Adenocarcinoma 12%
77. Genotype 12%
78. Memory 12%
79. Bupropion 12%
80. Pancreatic Neoplasms 12%
81. 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole 12%
82. Disease-Free Survival 12%
83. Symptom Assessment 12%
84. Anti-Inflammatory Agents 12%
85. Neoplasm Metastasis 12%
86. Brachytherapy 12%
87. Mortality 11%
88. INCB018424 11%
89. Veterans 11%
90. Randomized Controlled Trials 11%
91. Pharmaceutical Preparations 11%
92. Social Networking 11%
93. Rectal Neoplasms 11%
94. Endometrial Neoplasms 11%
95. Equipment and Supplies 11%
96. Databases 11%
97. Fatigue 11%
98. Squamous Cell Carcinoma 11%